Article
LymphGen-Sig: Integrating genetic and transcriptional states to predict therapeutic response in DLBCL
2026-03-02
Abstract excerpt
<h4>Purpose: </h4> Genetic classification may advance precision medicine in diffuse large B-cell lymphoma (DLBCL), but existing tools like LymphGen (LG) are limited by complexity, incomplete classification, and do not incorporate non-genetic features that impact disease biology and therapeutic outcomes. To address these limitations, we developed LymphGen-sig (LGsig), a gene expression-based platform that classifie...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fd514d7c-58b0-56cc-9214-487a4146a400
- DOI
- 10.64898/2026.02.20.26346725
